MyAverix Finance
F · Healthcare
GENETIC ANALYSIS NK -60 (8V8)
Diagnostics & Research
GENETIC ANALYSIS NK -60 (8V8) is listed on F in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 8V8
GENETIC ANALYSIS NK -60 (8V8) — FAQ
What is 8V8's P/E ratio?
The price-to-earnings (P/E) ratio for GENETIC ANALYSIS NK -60 (8V8) is 18.00 (data as of 2026-05-23).
Does GENETIC ANALYSIS NK -60 pay a dividend?
Dividend yield is not available in the current snapshot for GENETIC ANALYSIS NK -60 (8V8). Check the MyAverix Finance app for the latest dividend data.
What sector is GENETIC ANALYSIS NK -60 in?
GENETIC ANALYSIS NK -60 (8V8) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is 8V8 listed on?
8V8 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.